BackEpigenomics AG Overview

Epigenomics AG Current Cash

Latest current cash for EPGNY: $280K.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$277000.00
↓ 63.74% YoYΔ $-487000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Epigenomics AG Current Cash History

Loading

Epigenomics AG vs. peers: Current Cash Comparison

Loading

Epigenomics AG Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Epigenomics AG (EPGNY) FAQ

Epigenomics AG (EPGNY) currently reports a current cash of $280K as of June 2026. That compares with $760K in the prior-year period — down 63.7% year over year. Use the charts on this page to explore Epigenomics AG's current cash history and peer comparisons.

Epigenomics AG's current cash decreased from $760K to $280K — a 63.7% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Epigenomics AG reported $280K in current cash as of June 2026. That compares with $760K in the prior-year period — down 63.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $280K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Epigenomics AG, and consider following EPGNY for alerts when major investors trade the stock.